T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis

Brain, Behavior, and Immunity

Volumn 54, Issue , 2016, Pages 211-225

  Ferretti, M T ^a   Merlini, M ^a   Spani C ^a   Gericke, C ^a   Schweizer, N ^b   Enzmann, G ^c   Engelhardt, B ^c   Kulic, L ^a   Suter, T ^b   Nitsch, R M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Alzheimer's disease; Amyloid beta peptide; Interferon gamma; MHC II; T cell

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VASCULAR CELL ADHESION MOLECULE 1; AMYLOID PRECURSOR PROTEIN; CYTOKINE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BRAIN REGION; BRAIN TISSUE; CELL COMPARTMENTALIZATION; CELL MATURATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; FLOW CYTOMETRY; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; BRAIN; DISEASE MODEL; HUMAN; IMMUNOLOGY; METABOLISM; MICROGLIA; PATHOLOGY; PHENOTYPE; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; MICROGLIA; PHENOTYPE; PLAQUE, AMYLOID; T-LYMPHOCYTES; UP-REGULATION;

EID: 84958260758     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.02.009     Document Type: Article

References (58)

1. Aloisi F., Ria F., Adorini L. Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol. Today 2000, 21(3):141-147.
2. Aloisi F., Serafini B., Adorini L. Glia-T cell dialogue. J. Neuroimmunol. 2000, 107(2):111-117.
3. Anandasabapathy N., Victora G.D., Meredith M., Feder R., Dong B., Kluger C., et al. Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain. J. Exp. Med. 2011, 208(8):1695-1705.
4. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392(6673):245-252.
5. Baruch K., Rosenzweig N., Kertser A., Deczkowska A., Sharif A.M., Spinrad A., et al. Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology. Nat. Commun. 2015, 6:7967.
6. Butovsky O., Talpalar A.E., Ben-Yaakov K., Schwartz M. Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol. Cell. Neurosci. 2005, 29(3):381-393.
7. Carlos T.M., Schwartz B.R., Kovach N.L., Yee E., Rosa M., Osborn L., et al. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 1990, 76(5):965-970.
8. Carson M.J., Reilly C.R., Sutcliffe J.G., Lo D. Mature microglia resemble immature antigen-presenting cells. Glia 1998, 22(1):72-85.
9. Chakrabarty P., Ceballos-Diaz C., Beccard A., Janus C., Dickson D., Golde T.E., et al. IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice. J. Immunol. 2010, 184(9):5333-5343.
10. Ciccarelli O., Barkhof F., Bodini B., De Stefano N., Golay X., Nicolay K., et al. Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging. Lancet Neurol. 2014, 13(8):807-822.
11. Colton C.A. Immune heterogeneity in neuroinflammation: dendritic cells in the brain. J. Neuroimmune Pharmacol. 2013, 8(1):145-162.
12. Engelhardt B., Ransohoff R.M. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 2012, 33(12):579-589.
13. Enzmann G., Mysiorek C., Gorina R., Cheng Y.J., Ghavampour S., Hannocks M.J., et al. The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury. Acta Neuropathol. 2013, 125(3):395-412.
14. Ferretti M.T., Bruno M.A., Ducatenzeiler A., Klein W.L., Cuello A.C. Intracellular Abeta-oligomers and early inflammation in a model of Alzheimer's disease. Neurobiol. Aging 2011.
15. Fitzner D., Schnaars M., van Rossum D., Krishnamoorthy G., Dibaj P., Bakhti M., et al. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J. Cell Sci. 2011, 124(Pt 3):447-458.
16. Galea I., Bernardes-Silva M., Forse P.A., van Rooijen N., Liblau R.S., Perry V.H. An antigen-specific pathway for CD8 T cells across the blood-brain barrier. J. Exp. Med. 2007, 204(9):2023-2030.
17. Grammas P., Ovase R. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol. Aging 2001, 22(6):837-842.
18. Grant J.L., Ghosn E.E., Axtell R.C., Herges K., Kuipers H.F., Woodling N.S., et al. Reversal of paralysis and reduced inflammation from peripheral administration of beta-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis. Sci. Transl. Med. 2012, 4(145):145ra05.
19. Greter M., Lelios I., Croxford A.L. Microglia versus myeloid cell nomenclature during brain inflammation. Front. Immunol. 2015, 6:249.
20. Guilliams M., Ginhoux F., Jakubzick C., Naik S.H., Onai N., Schraml B.U., et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat. Rev. Immunol. 2014, 14(8):571-578.
21. Guillot-Sestier M.V., Doty K.R., Gate D., Rodriguez J., Leung B.P., Rezai-Zadeh K., et al. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 2015, 85(3):534-548.
22. Hellwig S., Masuch A., Nestel S., Katzmarski N., Meyer-Luehmann M., Biber K. Forebrain microglia from wild-type but not adult 5xFAD mice prevent amyloid-beta plaque formation in organotypic hippocampal slice cultures. Sci. Rep. 2015, 5:14624.
23. Heneka M.T., Carson M.J., El Khoury J., Landreth G.E., Brosseron F., Feinstein D.L., et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015, 14(4):388-405.
24. Hesske L., Vincenzetti C., Heikenwalder M., Prinz M., Reith W., Fontana A., et al. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation. Brain 2010, 133(Pt 6):1637-1654.
25. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996, 274(5284):99-102.
26. International Genomics of Alzheimer's Disease C International Genomics of Alzheimer's Disease Consortium I. Convergent genetic and expression data implicate immunity in Alzheimer's disease. Alzheimers Dement. 2015, 11(6):658-671.
27. Itagaki S., McGeer P.L., Akiyama H. Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue. Neurosci. Lett. 1988, 91(3):259-264.
28. Jankowsky J.L., Fadale D.J., Anderson J., Xu G.M., Gonzales V., Jenkins N.A., et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 2004, 13(2):159-170.
29. Jimenez S., Baglietto-Vargas D., Caballero C., Moreno-Gonzalez I., Torres M., Sanchez-Varo R., et al. Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. J. Neurosci. 2008, 28(45):11650-11661.
30. Knobloch M., Konietzko U., Krebs D.C., Nitsch R.M. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Neurobiol. Aging 2007, 28(9):1297-1306.
31. Koeppen A.H., Dickson A.C., McEvoy J.A. The cellular reactions to experimental intracerebral hemorrhage. J. Neurol. Sci. 1995, 134(Suppl.):102-112.
32. Krabbe G., Halle A., Matyash V., Rinnenthal J.L., Eom G.D., Bernhardt U., et al. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One 2013, 8(4):e60921.
33. Kulic L., McAfoose J., Welt T., Tackenberg C., Spani C., Wirth F., et al. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Abeta APP mutation. Transl. Psychiatry 2012, 2:e183.
34. Liu X., Zhan Z., Li D., Xu L., Ma F., Zhang P., et al. Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat. Immunol. 2011, 12(5):416-424.
35. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol. 2002, 23(9):445-449.
36. Maniega S.M., Valdes Hernandez M.C., Clayden J.D., Royle N.A., Murray C., Morris Z., et al. White matter hyperintensities and normal-appearing white matter integrity in the aging brain. Neurobiol. Aging 2015, 36(2):909-918.
37. Merlini M., Meyer E.P., Ulmann-Schuler A., Nitsch R.M. Vascular beta-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAbeta mice. Acta Neuropathol. 2011, 122(3):293-311.
38. Monsonego A., Maron R., Zota V., Selkoe D.J., Weiner H.L. Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(18):10273-10278.
39. Monsonego A., Imitola J., Petrovic S., Zota V., Nemirovsky A., Baron R., et al. Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(13):5048-5053.
40. Ousman S.S., Kubes P. Immune surveillance in the central nervous system. Nat. Neurosci. 2012, 15(8):1096-1101.
41. Parachikova A., Agadjanyan M.G., Cribbs D.H., Blurton-Jones M., Perreau V., Rogers J., et al. Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol. Aging 2007, 28(12):1821-1833.
42. Pober J.S. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells. Ciba Found. Symp. 1987, 131:170-184.
43. Prinz M., Priller J., Sisodia S.S., Ransohoff R.M. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat. Neurosci. 2011, 14(10):1227-1235.
44. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 2003, 3(7):569-581.
45. Rogers J., Luber-Narod J., Styren S.D., Civin W.H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 1988, 9(4):339-349.
46. Schmitt T.L., Steger M.M., Pavelka M., Grubeck-Loebenstein B. Interactions of the Alzheimer beta amyloid fragment (25-35) with peripheral blood dendritic cells. Mech. Ageing Dev. 1997, 94(1-3):223-232.
47. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 2004, 75(2):163-189.
48. Selkoe D.J. Alzheimer's disease. Cold Spring Harb. Perspect. Biol. 2011, 3(7).
49. Shinkai Y., Rathbun G., Lam K.P., Oltz E.M., Stewart V., Mendelsohn M., et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68(5):855-867.
50. Smolders J., Remmerswaal E.B., Schuurman K.G., Melief J., van Eden C.G., van Lier R.A., et al. Characteristics of differentiated CD8(+) and CD4 (+) T cells present in the human brain. Acta Neuropathol. 2013, 126(4):525-535.
51. Spani C., Suter T., Derungs R., Ferretti M.T., Welt T., Wirth F., et al. Reduced beta-amyloid pathology in an APP transgenic mouse model of Alzheimer's disease lacking functional B and T cells. Acta Neuropathol. Commun. 2015, 3:71.
52. Stichel C.C., Luebbert H. Inflammatory processes in the aging mouse brain: participation of dendritic cells and T-cells. Neurobiol. Aging 2007, 28(10):1507-1521.
53. Suter T., Biollaz G., Gatto D., Bernasconi L., Herren T., Reith W., et al. The brain as an immune privileged site: dendritic cells of the central nervous system inhibit T cell activation. Eur. J. Immunol. 2003, 33(11):2998-3006.
54. Togo T., Akiyama H., Iseki E., Kondo H., Ikeda K., Kato M., et al. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J. Neuroimmunol. 2002, 124(1-2):83-92.
55. Town T. Inflammation, immunity, and Alzheimer's disease. CNS Neurol. Disord.: Drug Targets 2010, 9(2):129-131.
56. Town T., Laouar Y., Pittenger C., Mori T., Szekely C.A., Tan J., et al. Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat. Med. 2008, 14(6):681-687.
57. von Andrian U.H., Mackay C.R. T-cell function and migration. Two sides of the same coin. N. Engl. J. Med. 2000, 343(14):1020-1034.
58. Wyss-Coray T., Rogers J. Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb. Perspect. Med. 2012, 2(1):a006346.